Pharmacological Targeting of Protease-Activated Receptor 2 Affords Protection from Bleomycin-Induced Pulmonary Fibrosis

Idiopathic pulmonary fibrosis is the most devastating diffuse fibrosing lung disease that remains refractory to therapy. Despite increasing evidence that protease-activated receptor 2 (PAR-2) contributes to fibrosis, its importance in pulmonary fibrosis is under debate. We addressed whether PAR-2 de...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Med
Main Authors: Lin, Cong, von der Thüsen, Jan, Daalhuisen, Joost, ten Brink, Marieke, Crestani, Bruno, van der Poll, Tom, Borensztajn, Keren, Spek, C Arnold
Formato: Artigo
Idioma:Inglês
Publicado em: The Feinstein Institute Press 2015
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4656197/
https://ncbi.nlm.nih.gov/pubmed/26147947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2015.00094
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados